Home Recalls D-1247-2016
Class II · Moderate risk Terminated Initiated May 13, 2016 (10 years ago)
THIAMINE 100 MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility
What was recalled
THIAMINE 100 MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
Recalling firm Medaus, Inc.
Origin AL, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-1247-2016
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Apr 8, 2026
Reason CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
Class II · Moderate risk Ongoing Apr 8, 2026
Reason CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Class I · High risk Ongoing Apr 8, 2026
Reason Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
Class III · Low risk Ongoing Apr 7, 2026
Reason Failed PH Specifications
Class II · Moderate risk Ongoing Jan 20, 2026
Reason CGMP Deviations